Mabwell (Shanghai) Bioscience Co., Ltd.(XSSC:688062) added to S&P Global BMI Index
Mabwell (Shanghai) Bioscience Co., Ltd.
Equities
688062
CNE100005RD2
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.4 CNY | -2.74% | +1.37% | +2.17% |
24/05 | Mabwell Announces 9MW2821 Clinical Data | CI |
13/05 | Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.17% | 1.9B | |
+18.70% | 123B | |
+14.97% | 107B | |
-4.04% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-12.04% | 16.23B | |
+2.03% | 13.43B | |
+24.18% | 11.32B |
- Stock Market
- Equities
- 688062 Stock
- News Mabwell (Shanghai) Bioscience Co., Ltd.
- Mabwell Bioscience Co., Ltd.(XSSC: 688062) added to S&P Global BMI Index